insights_auto
Why is ARX up 2,02%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
0,50 A$
arrow_upward
+2,02%(+0,0100) 1D
6 հոկ, 15:00:31 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,51 A$
High
0,51 A$
Low
0,50 A$
Mkt. cap
174,68 մլն
Avg. vol.
173,54 հզր
Volume
314,92 հզր
P/E ratio
48,51
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
Open
0,51 A$
High
0,51 A$
Low
0,50 A$
Mkt. cap
174,68 մլն
Avg. vol.
173,54 հզր
Volume
314,92 հզր
P/E ratio
48,51
52-wk high
0,80 A$
52-wk low
0,48 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
News stories
From web sources and news partners
GreenevilleSun.com
·
57 րոպե առաջ
US stocks rise to the edge of an all-time high
Yahoo Finance
·
1 ժամ առաջ
The Bond Market Just Sent Investors a Warning. Here's the Mistake I'd Avoid Making With the S&P 500.
AFP.com
·
1 ժամ առաջ
Asian stocks mixed despite tech-led Wall St record
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd